Investors might have begun to worry that Fulgent Genetics ' (NASDAQ: FLGT) freefall in recent months would never end. The genetic testing company's shares have plunged more than 50% from the highs set earlier this year.
Those worries might die down somewhat now, though. Fulgent announced its first-quarter results after the market closed Thursday. The life sciences stock jumped close to 4% in after-hours trading. Here are the highlights from Fulgent's Q1 update.
Image source: Getty Images.
For further details see:
Why Investors Loved Fulgent Genetics' Q1 Results